Association of Diabetes Care & Education Specialists

Login
Home Page
Your Personalized Guide
to AADE Resources
AADE GPS
My Profile
My Memberships
My Purchases
MY AADE NETWORK
My Open Invoices
Join Online
Online Store
Events
Make a Donation
Access My Learning
Access AADE7 System
Find a Diabetes Educator
Find an Accredited DSME Program
Apply For/Manage My DEAP Application
The Evolving Landscape of Glycemic Control: Navigating the Use of New Therapies

The Evolving Landscape of Glycemic Control: Navigating the Use of New Therapies

Quick Overview
Round table discussion on the use of new therapies for glycemic control, at AADE2016 ...
Cart
My Cart
Availability: In stock

Price: 0.00
Required
Description

The Evolving Landscape of Glycemic Control: Navigating the Use of New Therapies to Improve Patient Outcomes

Free to AADE Members
Recorded Round Table Discussion
Effective dates for CE credit: 10/10/16 – 10/10/18

Credit: 1.5 CE

Program Overview

This educational activity provides diabetes educators with guidance on pathophysiology and pharmacology for patients with type 2 diabetes mellitus (T2DM). At the roundtable discussion, a panel of thought leaders discuss how best to manage patients with T2DM. The findings from the recent clinical trials are presented along with expert opinion of how the results from these trials are anticipated to impact clinical practice. A series of case studies are also used to illustrate how learnings can be integrated into clinical practice.

Learners will take a pre-learning assessment, view the round-table discussion presentation, and then take a post-learning assessment. Learners must achieve a score of 70% or better on the post-learning assessment to earn their statement of credit for 1.5 CE. 

A downloadable copy of the presentation slides is included with the activity, for learners to use for future reference.

Purpose / Learning Outcomes

After completing this activity, the learner will be able to describe the pathophysiology of the various types of diabetes and to understand the actions of various classes of new medications that are available for treatment and how they will impact practice.

Activity Type:

This recording of a round table discussion and presentation is a knowledge-based learning activity.

Learning Objectives

At the end of this presentation, the participant will be able to:

- State the mode and target of action of at least 3 classes of type 2 diabetes (T2D) therapies to be better able to counsel patients on risks and benefits
- Identify effective combination therapies (both oral and injectable) for optimal glucose control and to help improve patient adherence
- Incorporate up-to-date clinical evidence on diabetes therapies to help patients achieve optimal outcomes

Intended Audience

Certified diabetes educators, nurses, pharmacists, dietitians and professionals involved in the care of patients with diabetes and other related conditions

Presenters

Joan Bardsley, RN, MBA, CDE
Assistant Vice President Special Projects
MedStar Health Research Institute
Great Falls, VA

Debbie Hinnen APN, BC-ADM, CDE, FAAN, FAAD
Advanced Practice Nurse and Certified Diabetes Educator
Memorial Hospital, University of Colorado Health
Colorado Springs, CO

Susan Cornell, BS, PharmD, CDE, FAPhA, FAADE
Associate Professor of Pharmacy Practice
Midwestern University – Chicago
Chicago, IL

Joshua J. Neumiller, PharmD, CDE
Associate Professor
Washington State University
Spokane, WA

Curtis Triplett, PharmD
Clinical Associate Professor
University of Texas Health Science Center/Texas Diabetes Institute
San Antonio, TX

Sponsorship

Supported by an educational grant provided by Novo Nordisk.

This educational activity is jointly provided by the American Association of Diabetes Educators and MCME Global.

Continuing Education Credit

This educational program will provide 1.5 contact hours of continuing education credit.

To successfully complete the program to earn CE credit, learners must take a pre-learning assessment, view the recorded session in its entirety, successfully complete the post-learning assessment with a score of 70% or better, and submit an evaluation survey. A continuing education statement of credit will be provided online.

Accreditation Information

Registered Nurses

The American Association of Diabetes Educators is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This educational program will provide 1.5 contact hours of continuing education credit.

AADE is accredited as a provider of continuing nursing education by the California Board of Registered Nursing (CEP # 10977).

Registered Dietitians

The American Association of Diabetes Educators, (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR credentialed practitioners will receive 1.5 continuing professional education units (CPEUs) for completion of these activities/materials. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

Registered Pharmacists

The American Association of Diabetes Educators is accredited bythe Accreditation Council for Pharmacy Education as a provider of continuingpharmacy education.  This programprovides 1.50 contact hours (0.150 CEU’s) of continuing education credit.

ACPE Universal Program Number: 0069-9999-16-252-H01-P
Effective Dates: 10/10/2016 – 10/10/2018

Faculty Disclosures

It is the policy of the American Association of Diabetes Educators to require that anyone who has an opportunity to affect continuing education activities content (e.g. authors, presenters and program planners) with products or services from a commercial interest with which s/he has financial relationships, discloses those financial relationship/s with commercial entities to participants.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant disclosures (or lack thereof) among educational activity faculty and planners are as follows:
Presenters
- Joan Bardsley, RN, MBA, CDE — Speakers Bureau: Novo Nordisk; Consultant: Eli Lilly Education Advisory Board
- Debbie Hinnen APN, BC-ADM, CDE, FAAN, FAAD — Speakers Bureau: Lilly/BI, Sanofi, Novo Nordisk, Janssen; Consultant: Sanofi, Lilly/BI, Janssen, Roche, CeQur, Novo Nordisk
- Susan Cornell, BS, PharmD, CDE, FAPhA, FAADE — Speakers Bureau: Sanofi; Novo-Nordisk advanced practitioner advisory board
- Joshua J. Neumiller, PharmD, CDE — Speakers Bureau: Novo Nordisk; Consultant: Eli Lilly, Sanofi; Research grant support from Novo Nordisk, Astra Zeneca, Johnson & Johnson, Merck
- Curtis Triplett, PharmD — Speakers Bureau: Boehringer Ingelheim, Astra Zeneca, Novo Nordisk; Consultant: Novo Nordisk, Sanofi

Planner
- Leslie E. Kolb, MBA, BSN, RN, AADE, Chicago, IL, has no relevant financial disclosures to report.

The approval of this educational offering by the AADE does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Originally presented on: 8/12/2016
CE valid dates: 10/10/2016 – 10/10/2018

Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Price

Members: $0
Non-Members: $34.95

Volume discounts are available and will be automatically applied at check-out when the desired quantity is selected
-- Groups of 4-9: 10% off
-- Groups of 10-19: 20% off
-- Groups of 20-29: 30% off
-- Groups of 30+ and Members: Contact education@aadenet.org to get a custom quote.

AADE CB's and LNG's: Please contact us at education@aadenet.org to order a recorded webinar for a group viewing.


We're sorry, but there is no inventory for the product you selected. Check out these other great products:

Related Items

    Products Others Bought

      Reviews
      No records found.